Header Logo

Connection

SUSAN BLANEY to Dasatinib

Back to Details
This is a "connection" page, showing publications SUSAN BLANEY has written about Dasatinib.
SUSAN BLANEY
Connection Strength
0.022
Dasatinib
  1. Pediatric phase I trial and pharmacokinetic study of dasatinib: a report from the children's oncology group phase I consortium. J Clin Oncol. 2011 Mar 01; 29(7):839-44.
    View in: PubMed
    Score: 0.022
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.